SCHEMBL10069265

SCHEMBL10069265

CCPc1ccc2cc(-n3cc(-c4ccc(N)cc4)nn3)c(=O)oc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 3/20 0.35
▸ ADRA1D P25100 2/20 0.35
▸ ADRA1B P35368 2/20 0.35
▸ SRC P12931 1/20 0.35
▸ PTGS2 P35354 1/20 0.34
▸ TLR8 Q9NR97 1/20 0.33
▸ NCOA1 Q15788 1/20 0.33
▸ NCOA3 Q9Y6Q9 1/20 0.33
▸ APP P05067 3/20 0.33
▸ P2RY14 Q15391 1/20 0.32
▸ CA12 O43570 2/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ CA9 Q16790 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13348930 0.82 ADRA1D (0.50) ADRA1AADRA1DADRA1BKDM4EALDH1A1
SCHEMBL2248079 0.79 BCHE (0.44) SRCPTGS2NCOA1NCOA3APP
SCHEMBL30425863 0.74 PGR (0.47) ADRA1AADRA1DADRA1BCA9KDM4E
SCHEMBL13315792 0.73 CA12 (0.47) CA12CA1CA2CA9L3MBTL1
SCHEMBL13315789 0.73 MIF (0.56) ADRA1AKDM4EALDH1A1MAPTHPGD
SCHEMBL30425440 0.73 MCL1 (0.46) CA12CA1CA2CA9KDM4E
SCHEMBL13315799 0.72 MAPT (0.58) ADRA1AADRA1DADRA1BKDM4EALDH1A1
SCHEMBL3550061 0.72 MAPT (0.60) ADRA1AADRA1DADRA1BKDM4EALDH1A1
SCHEMBL13315784 0.71 KDM4E (0.47) SRCPTGS2APPCA12CA1
SCHEMBL13315783 0.71 MEN1 (0.49) SRCAPPCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8552173-B2 Compositions, probes, and conjugates and uses thereof THIRD WAVE TECHNOLOGIES, INC. (US) 2013-10-08 — — US disclosed
US-20120010395-A1 COMPOSITIONS, PROBES, AND CONJUGATES AND USES THEREOF THIRD WAVE TECHNOLOGIES, INC. (US) 2012-01-12 — — US disclosed
US-8003771-B2 Compositions, probes and conjugates and uses thereof THIRD WAVE TECHNOLOGIES, INC. (US) 2011-08-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010395-A1 COMPOSITIONS, PROBES, AND CONJUGATES AND USES THEREOF ALKBH1, ALK, DUT ADRA1A 1771/4885ADRA1D 1749/4885ADRA1B 1802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback